SafeRX Pharmaceuticals

Early Stage

Invest in a solution to this crisis.

Analytics

Platform

Dalmore Group

Start Date

09/30/2021

Close Date

04/30/2022

Min. Goal

$25,000

Max. Goal

$5,000,000

Min. Investment

$500

Security Type

Equity - Common

Funding Type

RegCF

Series

Seed

Pre-Money Valuation

$46,630,282

Location

Lenox, Massachusetts

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

SafeRX Pharmaceuticals, with a valuation of $46.6 million, is raising funds on Dalmore Group. The company has patented a specific class of alcohol-resistant opioids that have the potential to prevent deaths caused by prescription overdose. The products of SafeRX Pharmaceuticals contain a combination of an FDA-approved opioid, an FDA-approved ALDI, and a tamper-resistant formulation. Michael Presti founded SafeRX Pharmaceuticals in May 2021. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $5,000,000. The campaign proceeds will be used for formulation development, clinical conduct, clinical study initiation, and clinical trials materials manufacturing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-822,403

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$175,149

$0

Accounts Receivable

$0

$0

Total Assets

$175,149

$0

Short-Term Debt

$817,551

$0

Long-Term Debt

$0

$0

Total Liabilities

$817,551

$0

Financials as of: 09/30/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Analyst Report

Other Deals

Responsum Health on Republic 2021

The company has created free and disease-specific apps to provide support and knowledge to people with chronic conditions. The apps…

Valuation Cap: $4,500,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $56,026 of $1,070,000 max
RegCF

JOGO Health on Wefunder 2021

The device is connected to a patent-protected mobile app that provides treatment protocols and games that work on neuromuscular reeducation,…

Valuation Cap: $20,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $3,417,309 of $3,500,000 max
RegCF

Koning on Republic 2021

The Koning Breast CT creates high-contrast 3D breast images with high spatial resolution and no painful compression. Dr. Ruola Ning…

Valuation Cap: $200,000,000
Min Investment: $100
Industry: Healthcare & Pharmaceuticals
Raised $587,984 of $5,000,000 max
RegCF

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
SafeRX Pharmaceuticals on Dalmore Group 2021
$
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $46,630,282

Follow company

Follow SafeRX Pharmaceuticals on Dalmore Group 2021